** Shares of medical software firm Omnicell OMCL.O fall as much as 16.7% to a near 10-month low of $25.39
** OMCL cuts its 2025 adj profit forecast to a range of $1 and $1.65 per share, compared with previously projected range of $1.65 to $1.85e
** Company, however, maintains its 2025 revenue forecast in the range of $1.11 billion to $1.16 billion
** Company posts Q1 revenue of $270 million vs analysts' estimates of $260 million - data compiled by LSEG
** Up to last close, stock had fallen 44.2% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.